FOR the first time in Asia, the smallest implantable cardiac monitoring device of its kind currently available was inserted into a patient at RIPAS Hospital yesterday afternoon.
According to a press release, the procedure to insert the Reveal LINQ Insertable Cardiac Monitor (ICM) device was done by Dr Sofian bin Dato Paduka Dr Hj Johar, Head of Cardiac Centre, RIPAS Hospital, and Dr Hj Nazar Luqman Bilgrami, Specialist Cardiologist of Cardiac Centre. Another two patients at RIPAS Hospital had the procedure done later that day.
The Reveal LINQ ICM is approximately one-third the size of a triple-A battery, making it more than 80 per cent smaller than the one previously used by the Cardiology Unit of RIPAS Hospital.
According to Dr Sofian, the REVEAL LINQ system has the potential to find answers to problems that may be related to the heart without affecting day-to-day activities.
“This device is much simpler to implant, with less discomfort and potentially fewer complications,” he said, adding that with its wireless capabilities will allow the possibility of frequent monitoring without the patient having to drop by the hospital.
Dr Sofian noted that patients can send a transmission to the hospital any time if they feel they have a problem.
“This will reassure patients the emergency response would be prompt,” he said. “The small size (of the device) may also allow more patients to accept this treatment and enable the diagnosis of patients whose cardiac conditions might not otherwise be treated.”
“While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years, with 20 per cent more data memory than its larger predecessor, REVEAL XT,” the press release stated.
The device sits just beneath the skin and is inserted through a small incision of less than 1cm.
Furthermore, as it is ‘MRI-conditional’, patients with this device will be able to still have MRI scans.
In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the ‘Carelink Network’. Through the Carelink Network, physicians can request notifications to alert them if their patients have had any cardiac episodes.
The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitation, syncope (fainting) and chest pain that may suggest a cardiac arrhythmia.
The device is also ideal for patient at increase risk for cardiac arrhythmias.